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1. Introduction 
Many factors can explain the most important increase of human life expectancy during the 
XXth century: better socioeconomic conditions, improved working conditions, development 
of preventive measures, less alcoholism, appearance of antibiotics, advances in medical 
practices, etc… At present, the fastest growing age group in western countries is people >80 
years old; they will represent 9–10.5% of the population in those countries in 2050. Today, 
life expectancy at 80 years is, on average, 10 years for a woman and 7 years for a man in 
western countries (Health at a glance OECD indicators). This population is at high risk of 
cardiovascular disease (Assey, 1993). More specifically, aortic stenosis (AS) is the most 
frequent valvulopathy in adults ≥ 75 years old, being present in as many 4.6% (Nkomo et al., 
2006). Progress made in anesthesia, surgery and intensive care explain why doctors, 
surgeons and cardiologists are less-and-less reluctant to propose aortic valve replacement 
(AVR) for older-and-older patients. 
However, for this very specific population, many questions remain to be answered before 
such surgery can be undertaken: 
- What is the spontaneous evolution of the disease? 
- Is there a therapeutic option other than surgery? 
- What are the postoperative results in terms of morbidity and mortality? 
- Will surgical treatment relieve the symptoms and improve the quality of life (QOL) at 
intermediate and long term? 
- What are the complications and constraints associated with the prosthesis? 
- Are those results universal? 
- Will my patient become frail or disabled after surgery? 
2. Rationale for proposing surgical AVR for the elderly  
2.1 Natural history of severe AS 
Above all, the natural history of severe aortic stenosis (SAS) has a dismal prognosis. Once 
symptoms appear, life expectancy is 5 years for angina, 3 years for dyspnea or syncope and 
2 years for cardiac failure (Chizner et al., 1980; Ross and Braunwald, 1968). Even though 
those results were obtained from old studies conducted during the 1960s and 1970s (Chizner 
et al., 1980; Horstkotte & Loogen, 1988; Ross & Braunwald, 1968), concerned young patients 
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(20 and 60 years old) and included small numbers of patients (15–55), more recent 
publications continue to emphasize the very poor natural history of SAS (Schueler et al., 
2010; Varadarajan et al., 2006).  
2.2 Failure of medical treatment 
The introduction of medical treatments, such as beta-blockers, statins and angiotensin-
converting–enzyme inhibitors, has not specifically modified SAS prognosis (Schueler et al., 
2010). Recently, Schueler et al. prospectively compared the prognoses of medically treated 
elderly SAS patients (mean age: 86 years) at high surgical risk to age- and sex-matched 
patients with non-severe AS; at 2 years, 41.8% and 59.8%, respectively, were survivors. 
Independent factors associated with death of SAS patients were Society Thoracic Surgeons 
predicted risk of mortality (STS-PROM) score (Shroyer et al., 2003), pulmonary arterial 
pressure >30 mm Hg, creatinine and diabetes (Schueler et al., 2010). Scharwz et al. (1982) 
compared the prognoses of 135 SAS patients treated surgically with AVR versus 19 denied 
surgery: at 3 years, 87% of the surgical group were alive vs 21% of medically treated group 
(p<0.001). Varadarajan et al. (2006) showed that conservatively treated SAS patients had 
poorer outcomes, with respective 1-, 5- and 10-year survival rates of 62%, 32% and 18%. 
2.3 Failure of balloon aortic valvuloplasty 
Although balloon aortic valvuloplasty (BAV) acutely increases the aortic valve area and 
attenuates symptoms, neither change significantly improved prognosis, with high mortality 
and complication rates (NHLBI Balloon Valvuloplasty Registry participants, 1991). 
Moreover, its restenosis rate at 1 year was >80% (Eltchaninoff et al., 1995). Current 
indications for BAV are very limited, with valvuloplasty primarily considered a bridge to 
surgery or transvalvular aortic implantation (TAVI) in hemodynamically unstable patients 
(Vahanian and Otto, 2010). 
Thus, for the time being, surgical AVR remains the treatment of choice for SAS. Notably, the 
international recommendations do not provide any specific guidelines concerning age 
(Bonow et al., 2006; Vahanian et al., 2007).  
2.4 Age, aging and prognosis  
Age is a known independent risk factor for in-hospital mortality after admission to the 
intensive care unit after cardiac surgery (Knaus et al., 1993; Roques & Nashef, 2003). 
However, although disease severity assessed with APACHE III can explain 80% of in-
hospital deaths, age can explain only 13% (Knaus et al., 1993). The mechanism of excess 
death independent of elderly patients’ disease severity has not yet been clearly elucidated. 
Setting aside the excess mortality linked to less intensive treatment of the elderly, it could be 
intrinsic, because of the greater vulnerability to disease, or extrinsic, attributable to a poorer 
response or even poorer tolerance of the therapeutic modalities used in intensive care. For 
both hypotheses, physiological particularities specific to the older patient are implicated. 
From a global perspective, Bouchon (1984) proposed a model in which morbidity of elderly 
patients resulted from 3 components (Figure 1). 
Clinically detectable morbidity is usually the sum of organ aging, possible organic 
deterioration resulting from more-or-less quiescent chronic disease and deterioration 
appended by acute disease. We cannot detail here all those deteriorations organ-by-organ 
(Somme et al., 2009), but retain the broad lines that transcend organ specificities. First, the 
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role of aging itself on organ decline is difficult to demonstrate. Indeed, a study on elderly 
individuals in very good health (old senior athletes) often had physiological cardiovascular 
system performances quite close to those of younger athletes but that is not the case for their 
osteoarticular system! Thus, the descriptions of so-called changes ‘linked’ to aging (i.e., 
frequent or typical of the old-old), be they histological or physiological performances, are 
the means of populations heterogeneous in terms of life style, exposures to personal or 
environmental risk factors and pathologies. When an attempt was made to show the same 
‘age-linked’ changes exclusively in healthy aged or physically fit subjects, none was found 
(Somme et al., 2009). Hence, defining the slope of line 1 for individuals is difficult (Fig. 1), as 
it depends, organ by organ, on personal and environmental factors. Nevertheless, it could be 
useful to predict vulnerability, like an old person’s response to treatment or knowing 
his/her level of physical activity, which is probably a better marker of physiological 
cardiovascular aging than chronological age. It is widely accepted that, for the young 
subject, cardiac function is the main parameter conditioning the maximal stress level, 
whereas for the elderly subject, it seems more often to be limited by respiratory function 
(Chan & Welsch, 1998). Finally, physiological aging can be represented as the functional 
state of adaptation mechanisms (or reserves) that are overwhelmed during stress or effort. 
These physiological particularities render the elderly more susceptible to acute diseases. 
This frailty should not limit access to intensive care for old patients, but should rather plead 
in favor of their adapted and early management. 
 
1+2+3
1+2
1+3
1
 
Fig. 1. Organ decline (regardless of the organ) due to aging is represented by slope 1. Two 
types of events are able to shift this organ under the threshold (dashed line) of organ 
insufficiency: a chronic (according to slope 2) or acute disease (the steepest slope 3). 
Adapted from 1+2+3: how to be effective in geriatrics? (Bouchon, 1984) 
2.5 Threshold of old age  
In practice, old age is defined 2 ways: that set by a chronological age and a dynamic 
approach taking into consideration the evolution of the health of the population. 
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The fixed chronological age definition (around 65–75 years for young-old; between 75–80 
and 85–90 for the old-old, and >85–90 for the oldest-old) is the most extensively used in the 
medical literature. It has the advantages of enabling comparisons between published 
historical data and not encouraging interpretation. However, it does not account for the 
evolution of life expectancy at 60 years and, even less, its evolution without handicap(s). 
Indeed, life expectancy for a 60-year-old man in France increased from 15.4 to 21.7 years 
between 1950 and 2010. This prolongation obviously has an impact on the premonitory 
usefulness of aggressive therapies, like cardiac surgery after 60 years during that interval. 
A dynamic definition of the old-age threshold can take those aspects into consideration. 
Several can be proposed but one seems readily accessible: survival at life expectancy at birth 
(Table 1). If we accept this definition, the percentage of ‘aged’ individuals (so defined) in 
France did not increase between 1950 (~11%) and 2010 (~9%), because life expectancy rose 
more quickly than the number of aged persons. 
 
 1950 2010 
Life expectancy at birth for males, years 63.4 78.1 
Life expectancy at birth for females, years 69.2 84.8 
Persons >65 years old in the  population  11.4%  
Persons >75 years old in the  population  9% 
Table 1. 1950 to 2010: Evolution of life expectancy in France and the aged population   
Age has always been identified as a major risk factor for mortality after cardiac surgery 
(Roques et al., 2003; Shroyer et al., 2003), but the mean age of operated patients is rising. 
Indeed, surgery on octogenarians is performed daily in western countries. Are there some 
limits for age and cardiac surgery? Florath et al. (2010) identified >84 years as an important 
independent risk factor for mortality 6 months after AVR for octogenarians. However, some 
publications indicated that surgeons seem less-and-less reluctant to operate on nonagenarians 
(Edwards et al., 2003; Praschker et al., 2006). During the 1980s, the age limit for cardiac 
surgery was progressively increased >80 years without drama considering outcomes 
(Edmunds et al., 1988). Should the story repeat itself for nonagenarians or even centenarians 
in the future? 
2.6 Postoperative outcomes of surgical AVR for octogenarians  
Surgical AVR results for octogenarians are acceptable and compare favorably with those of 
younger patients (Alexander et al., 2000; Thourani et al., 2008). Table 2 summarizes the early 
postoperative mortality (≤30 days) rate after AVR for octogenarians.  
De facto, studies during the 1990s and 2000s included more patients than during 1980s. For 
example, in the UK, between 1996 and 2003, the rate of surgery performed on octogenarians 
increased 2-fold, from 4.1% to 9.8% (Stoica et al., 2006). For the studies with >200 patients, 
early in-hospital mortality (≤30 days) ranged from 6.6% to 10.1%. Very few studies included 
only patients with isolated AVR (Table 2). Most studies included AVR with and without 
coronary-artery bypass graft (CABG). Postoperative mortality rates were higher when 
CABG was combined with AVR compared to AVR alone. 
However, the postoperative morbidity rate was very high for octogenarians after AVR 
(Melby et al., 2007; Thourani et al., 2008) and more than two-thirds of octogenarians will 
develop ≥1 postoperative complications (Collart et al., 2005; Kolh et al., 2007; Maillet et al., 
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2009). Descriptions of the complications, their definitions, their characteristics and rates 
varied widely from one study to another. The most frequent complications are transfusion 
(48.8–81.4%), new onset supraventricular arrhythmia (31.2–45.2%), low cardiac output  
(16.7–35.7%), prolonged mechanical ventilation (≥24 hours) (22–26%), reoperation for bleeding 
(6–9%), permanent strokes (3–6%), acute renal failure (4.6–12%), infections (2.4–5.6%) and 
heart block requiring a pacemaker (2.3–5%)  (Collart et al., 2005; Kohl et al., 2007; Maillet et 
al., 2009; Melby et al. 2007; Sundt et al., 2000; Thourani et al., 2008). 
 
First Author Year N Study 
period 
I AVR Mean 
age, 
yr 
Overall 
operative
mortality
Operative mortality 
I AVR   AVR+CABG 
Edmunds 
Levinson 
Bashour 
Culliford 
Freeman 
Olsson 
Elayda 
Tsai 
Asimakopoulos 
Sundt 
Sjögren 
Collart 
Chiappini 
Langanay 
Langanay 
Stoica 
Melby 
Kolh 
Huber 
Thourani 
Leonteyv 
Maillet 
Florath 
Folkmann 
1988
1989
1990
1991
1991
1992
1993
1994
1997
2000
2004
2005
2004
2004
2006
2006
2007
2007
2007
2008
2009
2009
2010
2010
50 
64 
24 
71 
87 
44 
152 
132 
1100
133 
117 
215 
115 
771 
442 
706 
245 
220 
136 
88 
282 
84 
493 
154 
1976–1987
1974–1987
1983–1986
1976–1988
1982–1986
1981–1989
1975–1991
1982–1992
1986–1995
1993–1998
1990–1993
1993–2003
1992–2003
1978–2003
2000–2004
1996–2003
1993–2005
1992–2004
1999–2003
1996–2006
1995–2006
1998–2003
1996–2006
2005–2007
66% 
50% 
50% 
50% 
50% 
100% 
45% 
42% 
100% 
33.1%
NR 
74% 
62.1%
85.2%
77.8%
27.2%
57% 
76% 
25% 
100% 
100% 
49% 
51% 
52% 
81 
82 
83 
82 
82 
82 
83 
83 
82 
84 
82 
83 
82 
83 
83 
83 
84 
83 
82 
83 
82 
84 
83 
83 
NR 
9.4% 
12.5% 
12.7 
15.7% 
14% 
17.5% 
4.5% 
6.6% 
11% 
3.4% 
8.8% 
8.5% 
10.1% 
7.5% 
9.8% 
9% 
13% 
4.4% 
5.7% 
9.2% 
16.7% 
8.4% 
7.8% 
30% 
3.2% 
8.3% 
5.7% 
9.6% 
14% 
5.2% 
1.8% 
6.6% 
NR 
NR 
NR  
NR 
NR 
NR 
9.4% 
10% 
 9% 
NR 
5.7% 
9.2% 
10.2% 
7.6% 
NR 
23.5% 
16.1% 
16.6% 
19.4% 
17.9% 
 
27.7% 
6.6% 
 
NR 
NR 
NR 
NR 
NR 
NR 
9.7% 
NR 
24% 
NR 
 
 
25.7% 
9.5% 
NR 
AVR = aortic valve replacement; I AVR = isolated AVR;  
CABG = coronary artery bypass graft; NR = not reported. 
Table 2. Postoperative mortality rates after AVR with/without CABG for octogenarians 
between 1976 and 2010 
2.7 Intermediate-term AVR results  
At intermediate term, all studies documented impressive symptom regression, with 73.2–
92.5% of the survivors being in New York Heart Association (NYHA) classification I or II 
(Collart et al., 2005; Kolh et al., 2007; Maillet et al., 2009,). The mean NYHA classification of 
survivors fell from 3.1 to 1.7 (p<0.001) (Sundt et al., 2000). Lastly, 91% of survivors were 
angina-free (Kolh et al., 2007).  
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Concerning the intermediate-term prognosis, crude results were good (Table 3), particularly 
compared with the natural course of SAS (Schwarz et al., 1982). At 5 years, survival ranged 
from 52% (Florath et al., 2010) to 82% (Stoica et al., 2006) for populations whose mean age at 
surgery was 83 years. Some authors reported a 30% 10-year survival rate with a Kaplan–
Meier median-survival estimate of 7.4 years (Thourani et al., 2008). Many studies also 
showed that, compared to an age- and sex-matched population, prognoses were comparable 
in different western countries: France (Maillet et al., 2009) and Sweden (Sjögren & Thulin, 
2004). Stoica et al. (2006) found that the standardized mortality ratio (observed postAVR 
mortality/observed mortality for matched population) was 45.6% in favor of the surgical 
population in the UK, with 5-year survival rates of 82.1% for the surgical group versus 
55.9% for a general population with the same age–sex distribution (p<0.001). The most 
common causes of late death were dominated by malignancy (20.5%), non-valve related 
cardiac failure (18.5%), valve-related stroke (18%) and pneumonia (11%) in a cohort of 1100 
elderly patients included in the UK Heart Valve Registry. It must be kept in mind that one-
third of the patients with malignancy died within 18 months after cardiac surgery. That 
observation emphasizes the improved preoperative cancer screening of elderly patients 
before AVR (Asimakopoulos et al., 1997). 
 
First Author Year N Study I Age at Survival at 
 
  
period AVR surgery 1 
year 
3 
years
5 
years 
8 
years 
Elayda 
Tsai 
Asimakopoulos
Sundt 
Chiappini 
Sjögren  
Collart 
Stoica 
Huber 
Kolh 
Melby 
Thourani 
Leontyev 
Florath 
1993
1994
1997
2000
2004
2004
2005
2006
2007
2007
2007
2008
2009
2010
171
132
1100
133
115
117
215
706
136
220
245
88 
282
493 
1975–1991
1982–1992
1986–1995
1993–1998
1992–2003
1990–1993
1993–2003
1996–2003
1999–2003
1992–2004
1993–2005
1996–2006
1995–2006
1996–2006
45% 
42% 
100% 
33.1%
62.1%
NR 
74% 
27.2%
25% 
76% 
57% 
100% 
100% 
51% 
83 
83 
82 
84 
82 
82 
83 
83 
82 
83 
84 
83 
83 
NR 
90.8%
82% 
89% 
80% 
86.4%
92.3%
84% 
83.7%
94% 
85.5%
82% 
87% 
81% 
82% 
84.2%
 
 
 
 
 
 
 
94% 
80.8%
70% 
68.2%
71% 
 
76% 
62% 
69% 
55% 
69.4% 
65% 
56% 
82.1% 
75% 
73.2% 
56% 
61% 
57% 
52% 
 
 
45.8% 
 
 
 
 
 
 
 
 
 
 
30% 
AVR = aortic valve replacement; I AVR = isolated AVR; NR = not reported. 
Table 3. Intermediate-term AVR outcomes of octogenarians  
2.8 Impact of AVR on QOL among octogenarians 
Improving QOL is one of the most important aims of AVR especially for octogenarians. 
Authors of retrospective studies concluded that QOL was good after AVR at intermediate 
term but, in many studies, preoperative QOL had not been evaluated (Maillet et al., 2009; 
Sundt et al., 2000). Using the medical outcomes study Short Form-36 (SF-36), Sundt et al. 
(2000) showed that the QOL of a surgical population with a mean age of 84 years was 
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comparable to that predicted for the general population >75 years old. Olsson et al. (1996), 
prospectively compared QOL evolution for 2 groups of patients referred for isolated AVR; 
30 octogenarians vs 30 patients 65–75 years old. At 1-year postAVR, octogenarians, despite 
their more compromised preoperative status, had markedly regressed symptoms, and their 
physical abilities and general well-being were of a similar magnitude to those of the 
younger patients. Those improvements appeared as of 3 months. With mean follow-up of 
8.3±1.9 years, Sjögren & Thulin (2004) found long-term postoperative QOL to be comparable 
to that of an age-matched population. In addition, Huber et al. (2007) showed that 97% of 
the survivors lived in their own homes. Finally, 81% had no or few self-perceived 
restrictions in their daily activities (Kohl et al., 2007), 93% felt much better after the 
operation and 81% of octogenarians had few disabilities in daily activities (Huber et al., 
2007). Also, QOL was not affected by the constraints entailed by treatment(s) associated 
with the type of prosthesis. Indeed, after postoperative month 3, >90% who had received a 
bioprosthesis were in sinus rhythm and were taking only low-dose aspirin. Vicchio et al. 
(2008) compared the QOL of 62 octogenarians with bioprosthetic valves vs 98 with 
mechanical valves during a mean follow-up of 3.4 ± 2.8 years and found that the prosthesis 
type had no impact on their QOL. 
2.9 Limitations of those studies 
However, all those studies had some limitations. Indeed, all of them were retrospective 
except for Olsson et al. (1996). Only those by Asimakopoulos et al. (1997) and Stoica et al. 
(2007), representing UK registry results, were multicenter investigations. Very few studies 
specifically and exclusively evaluated the outcomes of isolated AVR for SAS (Asimakopoulos 
et al., 1997; Leonteyv et al., 2009; Thourani et al., 2008). Some studies mixed AVR with 
CABG or other operations, whereas others mixed AVR for SAS or severe aortic insufficiency 
(i.e., Stoica et al., 2006; Sundt et al., 2000).  The sample sizes also varied widely from one 
study to another: ranging from 24 (Bashour et al., 1990) to 1100 patients (Asimakopoulos et 
al., 1997). Lastly, those studies retrospectively covered long periods, lasting 5 (Sundt et al., 
2000) to 16 years (Elayda et al., 1993). 
2.10 Decision-making 
Those results must be interpreted carefully, keeping in mind that octogenarians with SAS 
referred to a surgeon are highly selected, as that decision-making is complex. Bouma et al. 
(1999) showed that only 59% of the patients who should have had an AVR according to 
international guidelines (Bonow et al., 2006) were actually offered surgical treatment. They 
were mainly symptomatic, >80 years old and had high transaortic valve gradients. On the 
other hand, Iung et al. (2005) observed that a decision not to operate was made for 33% of 
SAS patients. Multivariate analyses retained left ventricular ejection fraction and age (OR 
1.84 for 80–85 year olds, OR = 3.38 for those ≥85 years) as being significantly and 
independently associated with the decision not to operate. Neurological dysfunction was 
the only comorbidity associated with that decision. During 2007, Freed et al. (2007) 
retrospectively studied the outcomes of SAS patients referred to their echocardiography 
laboratory. Among the 106 SAS patients, only 31% underwent surgery. The most common 
reasons symptomatic SAS patients did not undergo AVR were: their symptoms were 
thought to be unrelated to AS, too high surgical risk and/or patients refused (Freed et al., 
2010). 
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3. Promises of a new approach: TAVI 
In light of increasing life expectancy, the high incidence of AS in the elderly, the fact that 
many SAS patients are denied surgery, and because of improved endovascular technology, 
a new therapeutic approach using new devices is rapidly evolving, becoming widespread 
and would revolutionize AS treatment: TAVI. 
After successful animal experimentation, Cribier et al. (2002) successfully performed the first 
human implantation of a balloon-expandable aortic valve prosthesis. Two TAVI devices are 
now under postmarketing surveillance in Europe: the balloon expandable Edwards 
SAPIEN™ prosthesis (Edwards Life-Sciences, CA) and the self-expandable CoreValve 
Revalving prosthesis™ (Medtronic Inc, MN). Two approaches are used: anterograde with 
transapical (TA) access or retrograde with transfemoral (TF) access. Two videos illustrating 
the TAVI procedures are available at www.NEJM.com. 
3.1 Postoperative and short-term TAVI results  
The first step in the development of these devices was to demonstrate a high rate of 
successful implantation that is improving with time, from 88% to >98% (Grube et al., 2007; 
Tamburino et al., 2011; Webb et al., 2009). At 30 days, outcome was good with 9–18% 
mortality (Zajarias & Cribier, 2009) for high-risk patients for whom surgery was denied 
(octogenarians, high Logistic EuroSCORE ≥20% (Roques & Nashef, 2003), STS-PROM ≥10% 
(Shroeyr et al., 2003) or specific surgical contraindication(s) (e.g. porcelain aorta, history of 
mediastinal radiotherapy). In all studies, the observed mortality was below those predicted 
by STS-PROM or Logistic EuroSCORE. 
Surgery relieved symptoms with systematically lower NYHA classification and impressive 
decreases of the mean transvalvular gradient from 46 mm Hg preoperatively to 10 mm Hg 
thereafter, associated with increased aortic surface from 0.6 to 1.6 cm2, respectively, for 
example, in the study by Webb et al. (2009). The NYHA classification and 
echocardiographically detected improvement of the mean gradient and aortic surface were 
sustained at 1 year (Tamburino et al., 2011; Webb at al., 2009). Survival at 1 year ranged from 
73.8% (Webb et al., 2009) to 85% (Tamburino et al., 2011) and compared favorably with the 
spontaneous SAS evolution.  
Prognosis at 1 year seems mostly related to comorbidities rather than cardiac status (Webb 
et al., 2009). In an Italian multicenter study, independent risk factors associated with late 
death were: prior stroke (hazard ratio (HR) 5.4; 95% confidence interval (CI) 1.47–20.39; 
p=0.01), prior acute pulmonary edema (HR 2.7; 95% CI, 1.1–6.7: p=0.03), chronic kidney 
disease (HR 2.5; 95% CI 1.0–6.4; p=0.048) and postprocedural paravalvular leak ≥2+ (HR 3.8; 
95% CI 1.6–9.1: p=0.03) (Tamburino et al., 2011). 
A landmark multicenter, prospective, randomized trial compared SAS patients, who 
surgeons considered unsuitable surgical candidates and were given standard treatment 
(including BAV) or TF transcatheter implantation of a balloon-expandable bovine 
pericardial valve (Leon et al., 2010). At 1 year, the death rate from any cause was 30.7% with 
TAVI and 50.7% with standard therapy (TAVI HR 0.55; 95% CI 0.4–0.74; p<0.001). 
A principal concern of TAVI for octogenarians is its impact on QOL, for which data are 
scarce. At 3 months postTAVI, Krane et al. (2010) used SF-36, and found significantly 
improved QOL concerning the physical health summarized score, while the mental health 
summarized score remained unchanged. For a population ≥81 years, comparison of 6 
months postTAVI to preoperative SF-36 data, Bekeredjian et al. (2010) obtained significantly 
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improved physical and mental component summary scores from 28.4±10 to 46.8±9.2 
(p<0.001) and from 37.3±10.8 to 50.6±10.1 (p<0.001), respectively. 
3.2 Specific TAVI-related complications  
The results of all studies demonstrated that TAVI can be implanted safely, with 
intraprocedural mortality now a mean of 1% (Webb et al., 2009; Tamburino et al., 2011). 
Implantation failure is becoming rare, with the successful implantation rate ≥98% in the 
most recent studies (Bleiziffer et al., 2009; Tamburino et al., 2011). Changing the surgical 
approach during the intervention has also become very rare. 
Coronary obstruction rarely complicates valve implantation (<1%). Valve positioning is 
challenging, particularly when the distance between the annulus and the coronary artery is 
short, as the native valve may be pushed against the coronary ostium (Lefèvre et al., 2011). 
Some complications seem to be related to the access route used. With TF access, major 
vascular complications occur in 6.8–11.7% of the cases (Bleiziffer et al., 2009; Webb et al., 
2009). However, technological advances have permitted sheath-size reduction from 24F to 
18F, thereby allowing a percutaneous procedure with locoregional anesthesia and fewer 
vascular injuries. Improved screening, case selection and experience should surely lower the 
vascular injury rate further. 
Second, 10% of the patients suffer clinical strokes (Grube et al. 2007). In a recent diffusion-
weighted, magnetic resonance imaging study on TAVI patients, the risk of diffuse cerebral 
embolism was 72.7%, with patients frequently having multiple new but clinically silent 
brain lesions. Although cerebral embolism was extremely common in the TF-TAVI cohort, 
the clinical stroke rate was 3.6% (Ghanem et al., 2010). It was suggested that TA-TAVI might 
be associated with fewer cerebral embolic events. However, results are controversial and 
further studies with larger cohorts are needed. Two mechanisms are involved: aortic 
atheroemboli and valvular calcific emboli. The elderly are at particularly high risk for 
perioperative neurological events because of advanced cerebral ischemic disease present 
preoperatively (Wang et al., 2010). 
For both accesses, annulus measurement is challenging. Indeed, no gold standard currently 
exists for aortic annular measurement but transesophageal echocardiography provides 
accurate data to guide valve sizing before implantation (Messika-Zeitoun et al., 2010). 
Paravalvular aortic regurgitation is common after TAVI but remains stable at late follow-up 
(Webb et al., 2009). In the PARTNER study, moderate-or-severe perivalvular leakage was 
present in 11.8% of the patients at 30 days and 10.5% at 1 year (Leon et al., 2010). However, 
postprocedural paravalvular aortic regurgitation ≥2+ (HR 3.79) mainly affected later 
outcomes between 30 days and 1 year (Tamburino et al., 2011). 
Conduction abnormalities are frequent after TAVI (Roten et al., 2010). The occurrence of 
atrioventricular block requiring pacemaker insertion at 30 days seems lower with the 
Edwards SAPIEN™ (<5%) (Lefèvre et al., 2011) than the CoreValve™ (up to 30%) (Jilaihawi 
et al., 2009). One possible explanation could be that the CoreValve™ was designed to be 
seated lower than the SAPIEN™ valve and might compress the underlying conduction 
system. However, based on a cohort of 67 patients (41 received CoreValve™ and 26 
SAPIEN™), Roten et al. showed that the sole independent risk factor for complete 
atrioventricular block after TAVI was preexisting right bundle branch block (Roten et al., 
2010). Because prosthesis sizing is a critical issue, to avoid perivalvular leakage and valve 
migration, “over sizing” of TAVI might have increased the risk of atrioventricular block 
(Bleiziffer et al., 2009). Further investigations are mandatory. 
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The results of some studies showed that the postoperative and short-term outcomes were 
worse for patients treated with TA than TF access, because the former were more severely ill 
and had more severe comorbidities. The Logistic EuroSCORE predicted risk was 
significantly higher for TA than TF, respectively: 35% vs 25% (p=0.01), as did STS-PROM 
10.3% vs 8.7% (Webb et al., 2009). In-hospital mortality was 8% for the TF group vs 27% for 
TA group, with respective 1-year survival rates of 74±11% vs 60±13% (Al-attar et al., 2009). 
At 1 year, the European PARTNER study results were comparable (Lefèvre et al., 2011). 
3.3 Risk assessment and patient selection  
TAVI development has highlighted the complexity of risk assessment and patient selection. 
At present, TAVI is indicated only for SAS patients ineligible for conventional AVR, but the 
definition of “ineligible” remains vague. TAVI was initially designed to treat old-old 
patients, mean age 81–86 years (Bleiziffer et al., 2009; Tamburino et al., 2011), with high 
Logistic EuroSCORE predicted risk ≥20%, mean range 22–29% (Grube et al., 2007; Webb et 
al., 2009) or STS-PROM score ≥10%, mean range 16–23% (Al-attar et al., 2009; Bleiziffer et al., 
2009) or with contraindication(s) for surgery.  
Logistic EuroSCORE and STS-PROM scores are increasingly being used to estimate 
operative mortality based on cardiac and extracardiac factors. The STS-PROM score appears 
to be more reliable than the EuroSCORE for predicting outcomes of high-risk AVR patients. 
However, STS-PROM tends to underestimate mortality (Dewey et al., 2007). A meta-analysis 
showed EuroSCORE to have low discrimination ability for valve surgery and it slightly over 
predicted risk (Parolari et al., 2010), particularly for octogenarians referred for AVR 
(Leontyev et al., 2009). Both scores share the same limitations: predictive ability is limited for 
high-risk patients, who represented only a small proportion of the population used to derive 
them. They do not take into account the surgical results in a given institution, relationship 
between volume and mortality, and the impact of progress concerning surgical techniques, 
cardiopulmonary bypass, anesthesia and intensive care. The scores also fail to evaluate fully 
the high-risk patient because they do not integrate a very important element: clinical 
judgment. Indeed, many factors that negatively influence prognosis are not considered: 
cirrhosis, impact of body mass index, chest irradiation, chest deformation, multivalve 
surgery, porcelain aorta, previous CABG and vascular tortuosity for TAVI. It is estimated 
that neither the Logistic EuroSCORE nor STS-PROM would have classed approximately 
one-quarter of the patients at high risk and yet they were refused surgery because of such 
factors (Webb et al., 2009). 
For the specific SAS octogenarian population, it seems that the development of a new 
specific scoring classification is necessary (Florath et al., 2010), especially one including 
demographic variables, such as nutritional status, disability, dementia and frailty. 
3.4 Unanswered questions concerning TAVI 
TAVI is not suitable for all patients ineligible for conventional AVR and patients referred for 
TAVI are also highly selected. In a cohort of 469 SAS patients referred for participation in a 
TAVI trial, 362 (77.1%) patients did not meet the inclusion/exclusion criteria. The main 
exclusion criteria were low STS-PROM score <10% (72 patients), peripheral vascular or aorta 
disease (58 patients), aortic valve area >0.8 cm2 (54 patients), significant coronary artery 
disease (43 patients) and renal failure (25 patients). Among those 362 patients, 75 (20.7%) 
had 2 exclusion criteria and 26 (7.1%) had 3 exclusion criteria. Eighty-eight patients 
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underwent surgery and 274 were treated medically, 177 of whom had BAV. At 2 years, the 
mortality rate was significantly lower for the surgical group vs the medically treated group, 
respectively, 28.1% vs 53.4% (p<0.001) (Ben-Dor et al., 2010). Another TAVI limitation is also 
the high incidence of severe coronary artery disease among elderly SAS patients that also 
influences prognosis and requires specific treatment.  
Long-term durability of TAVI must now be demonstrated. TAVI provides acceptable 
hemodynamic results up to 3 years (Webb et al., 2009). At present, outcomes reflect 
comorbidities rather than cardiac status (Tamburino et al., 2011). Patient selection is a major 
concern for long-term durability evaluation of TAVI. Future studies should include patients 
with expected life expectancy unrelated to cardiac disease >5 years. At 2 years, survival was 
60.9% in the study by Webb et al. (2009); what will the sample size be at 5 years?  
With the learning curve, technological improvement and better patient selection, TAVI-
related morbidity should decline, particularly concerning vascular injuries, strokes, 
pacemaker implantation and perivalvular leakage. 
The next step for TAVI for SAS management should be its direct comparison with surgery 
for high-risk patients without contraindication(s) for surgery, and then for intermediate- 
and low-risk patients. Historical comparisons, case–control studies, propensity-score 
matching (Johansson et al., 2011) or comparison with spontaneous evolution are not able to 
answer these questions adequately. Multicenter, randomized–controlled trials should 
answer them (prognosis, durability, specific morbidity, etc…) in few years, thereby allowing 
the widespread development of this very promising technique.  
4. Frailty and geriatric evaluation of octogenarians for SAS management  
4.1 Frailty 
To evaluate better an individual’s situation on which the final therapeutic decision generally 
depends, the concepts of frailty or vulnerability are the themes of several international 
gerontology publications. We highlight that, at present, no consensual definition of frailty 
exists (Bergman et al., 2007; Karunananthan et al., 2009). However, the various authors agree 
that frailty is a state of susceptibility to aggression, which explains that, for a given health 
event, despite the same management and apparently sufficiently similar health status, the 
individuals will have very different outcomes. Thus, frailty is always defined as a function 
of the event that serves as the judgement criterion: falls, loss of autonomy, 
institutionalization, death… It is also defined by the time at which it is assessed. Therefore, 
an effective definition over the long term (Province et al., 1995) might not be operative to 
distinguish individuals in terms of consequences of hospitalization (Gill et al., 2004).  
Regardless of the definition retained, the authors defined a certain number of common 
characteristics (Rockwood, 2005): frailty is a continuous state that is not simply present or 
absent; it is not the consequence of single organ involvement; the clinical manifestations are 
multiple. It can be recognized clinically, with that identification being considered the 
threshold of entry into frailty, the occurrence of the negative event marking the end of 
frailty in relationship to this factor (institutionalization or handicap, for example). The 
definitions of frailty are multiple (Ferrucci et al., 2004), but the most used are those that refer 
to the diminished physiological reserves, with a core event being the development of 
sarcopenia. This type of definition has shown its efficacy to predict the loss of autonomy, 
institutionalization or death in a cohort of patients with cardiovascular diseases but not 
initially handicapped and followed for 1 year (Fried et al., 2004). Its effect can be associated 
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with those of a disability and comorbidity, even though none of these 3 dimensions is 
superimposable or sufficient alone to explain the outcome (Fried et al., 2004).  
According to those authors’ definition (Fried et al., 2004), at least 3 criteria among the 
following must be satisfied to be qualified as ‘fragile’: diminished gripping force of the 
dominant hand, the feeling of fatigue/exhaustion, slower walking speed and non-
intentional weight loss. Each of the elements is evaluated according to precise criteria. Such 
a definition could prove useful to study the long-term outcome of patients after cardiac 
surgery. In addition, this type of definition conceptually excludes the cognitive, sociofamilial 
and psychological dimensions of frailty (Fried et al., 2004). To take those dimensions into 
account, 2 types of solutions are proposed: an inventory of the situations at risk that can be 
extremely complex and overall clinical judgment, whose pertinence concerning loss of 
autonomy and death were recently validated (Jones et al., 2005). 
4.2 Frailty and cardiac surgery  
The concept of frailty and its clinical use in surgery in general and, more specifically, cardiac 
surgery, has recently appeared in the literature. Two recent studies (Afilalo et al., 2010; Lee 
et al., 2010) documented that frailty increased the risk of complications after cardiac surgery 
independently of age and included information from standard prognostic scores. Pertinently, 
those 2 studies are complementary.  
Indeed, Afilalo et al. (2010) defined frailty as requiring assistance to accomplish at least one 
essential life activity, a diagnosis known of dementia or limited mobility. Although their 
definition can be debated on a conceptual level, because it mixes disability and fragility, it 
has the advantage of being clinically operational. The existence of a frailty phenotype, as 
defined, was independently associated with mortality (OR 1.8 [95% CI 1.1–3.0]), 
institutionalization and discharge from that facility (OR 6.3 [95% CI 4.2–9.4]) and 
intermediate-term survival (OR 1.5 [95% CI 1.1–2.2]).  
Lee et al. (2010) defined frailty more precisely and more sensitively: walking speed tested as 
a mean time needed to go 5 m during 3 consecutive tries (limited to 6 seconds). Their 
definition is directly in line with the conceptual frailty–sarcopenia model. In their study, the 
risk of postoperative morbidity–mortality was multiplied by 3.05 [95% CI 1.23–7.64] for frail 
patients, even after adjustment for the STS-PROM score. In addition, frailty defined in this 
way doubled the risk of institutionalization or a prolonged stay there. Finally, in a manner 
not entirely clear, the risks linked to frailty are greater for women than men. 
The results of those studies confirmed the findings of others concerning non-cardiac 
surgery, i.e., that such a definition of frailty is associated with “geriatric syndromes” 
(Robinson et al., 2009), sarcopenia (Makary et al., 2010) or a more holistic score-based 
definition (Dasgupta et al., 2009). In all those cases, the frailty phenotype was independently 
associated with age and other known prognostic factors of higher risk of morbidity and/or 
mortality. 
Only authors of rare studies have envisaged frailty’s appearance as a surgical consequence. 
Researchers of a single center study supported that hypothesis and strongly recommended 
that the appearance of that phenotype should be considered in future outcome investigations 
because this fragility is linked even more strongly to QOL than self-reported overall 
assessments of “health status” (Maillet et al., 2009). 
We would also like to underscore the areas of uncertainty that persist today and that 
represent as many research projects. Afilalo et al.’s (2010) and Lee et al.’s (2010) examinations 
of potential relationships between a frailty phenotype and outcomes after cardiac surgery 
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were based on large majorities of patients (>60%) who underwent simple coronary artery 
bypass surgery. Even though the type of intervention was entered into the model, the 
phenotype’s effect on valve-surgery complications (and even more so for the newer 
interventional techniques) warrants further clarification. The models currently used in 
cardiac surgery are mainly based on the frailty–sarcopenia concept. The contributions of 
other frailty dimensions to explaining outcome (biological, psychological, environmental 
and social) are also worthy of more detailed exploration. Finally, the available studies 
focused on subjects who were certainly old (>70 years), but the usefulness of the scores and 
the thresholds applied undoubtedly need to be adapted for the oldest–old (>85–90 years). 
4.3 Contribution of geriatric evaluation to AVR decision-making  
All of the above underscore the complexity of decision-making and follow-up of the oldest-
old when AVR becomes necessary, and support an interdisciplinary approach bringing 
together cardiologists, surgeons, geriatricians, anesthesiologists and intensivists. However, 
convincing data on the impact of a geriatric approach in this setting are still lacking. The 
geriatrician is most probably in an ideal position, in terms of professional competence, to 
detect frailty, but the impact of this identification on the decisions to be made and, even 
more so, on the outcomes are not yet documented. As we have seen, it is also likely that the 
consequences of cardiac surgery, beyond its cardiovascular impact, are multidimensional 
(Maillet et al., 2009). It seems highly probable that an overall approach, like that proposed 
by geriatricians in another context (Rydwik et al., 2008), would contribute to improving the 
outcomes of individuals, not only in functional terms but also nutritional, psychological, 
social and even cognitive aspects.  
4.4 Adapted rehabilitation 
Rehabilitation after cardiac surgery is not less effective in the elderly than young patients 
(Macchi et al., 2007; Pasquali et al., 2001) and improves the outcome, even though 
information on the oldest-old are scarce (Pasquali et al., 2001). Indeed, it seems, for the aged 
patient, that rehabilitation after cardiac surgery should not be postponed and should be 
prolonged (Macchi et al., 2009). This is especially true for women >80 years who achieve a 
gain in functional autonomy 1 year after the intervention (Barnett & Halpin, 2003). Some 
authors recommend particular preoperative precautions, notably respiratory. The preoperative 
identification of frail patients could also be a pertinent way to select patients likely to benefit 
the most from specific programs, e.g., early mobilization in the intensive care unit 
(Needham, 2008). Multidimensional rehabilitation programs also achieved favorable results 
(Eder et al., 2010; Mazza et al., 2007; Opasich et al., 2010), which, in addition, proved their 
safety and efficacy in terms of rehabilitation, nursing needs, mobility capability, muscle 
force, equilibrium and, last but certainly no least, duration of stay. 
5. Conclusion 
Surgical AVR for SAS in octogenarians is the treatment of choice and is performed daily, 
with good intermediate-term results, despite high postoperative morbidity. In the very near 
future, TAVI should profoundly modify the treatment strategy for SAS. Despite all the 
improvements since the beginning of cardiac surgery, much progress remains to be 
achieved in all the steps: improving patient selection, more accurately stratifying the risks, 
choosing the best treatment, limiting morbidity regardless of the technique used, and 
www.intechopen.com
 
Aortic Valve Surgery 
 
180 
proposing a personalized and adapted rehabilitation program. New scoring systems, 
including specific markers for elderly patients (disability, frailty, etc…), should be 
developed. A multidisciplinary approach, including surgeons and cardiologists, along with 
geriatricians, intensivists and rehabilitation specialists, would contribute to achieving all 
those improvements. The scarcity of scientific literature on the link between age (and 
particularly old-old age >85 years), outcomes and the frailty-syndrome subset opens vast 
avenues for future research. 
6. References 
Afilalo, J., Eisenberg, M.J., Morin, J.F., Bergman, H., Monette, J., Noiseux, N., Perrault, L.P., 
Alexander, K.P., Langlois, Y., Dendukuri, N., Chamoun, P., Kasparian, G., 
Robichaud, S., Gharacholou, S.M., & Boivin, J.F. (2010). Gait speed as an 
incremental predictor of mortality and major morbidity in elderly patients 
undergoing cardiac surgery. J Am Coll Cardiol, 56, 1668–1676, ISSN 0735-1097 
Al-Attar, N., Himbert, D., Descoutures, F., Iung, B., Raffoul, R., Messika-Zeitoun, D., 
Brochet, E., Francis, F., Ibrahim, H., Vahanian, A., & Nataf, P. (2009). Transcatheter 
aortic valve implantation: selection strategy is crucial for outcome. Ann Thorac Surg, 
87, 1557–1563, ISSN 0003-4975 
Alexander, K., Anstrom, K.J., Muhlbaier, L.H., Grosswald, R.D., Smith, P.K., Jones, R.H., & 
Peterson, E.D. (2000). Outcomes of cardiac surgery in patients ≥ 80 years: results 
from the national cardiovascular network. J Am Coll Cardiol, 35, 731–738, ISSN 0735-
1097 
Asimakopoulos, G., Edwards, M.B., & Taylor, K.M. (1997). Aortic valve replacement in 
patients 80 years of age and older: survival and cause of death based on 1100 cases: 
collective results from the UK Heart Valve Registry. Circulation, 96, 3403–3408, ISSN 
0009-7322 
Assey, M.E. (1993) Heart disease in the elderly. Heart Dis Stroke, 2, 330–334, ISSN 1058–2819 
Barnett, S.D., & Halpin, L.S. (2003). Functional status improvement in the elderly following 
coronary artery bypass graft. J Nurs Care Qual, 18, 281–287, ISSN 1057-3631 
Bashour, T.T., Hanna, E.S., Myler, R.K., Mason, D.T., Ryan, C,. Feeney, J., Iskikian, J., Wald, 
S.H., Antonin, C., Sr., & Malabed, L.L. (1990). Cardiac surgery in patients over the 
age of 80 years. Clin Cardiol, 13, 267–270, ISSN 0160-9289 
Bekeredjian, R., Krumsdorf, U., Chorianopoulos, E., Kallenbach, K., Karck, M., Katus, H.A., 
& Rottbauer, W. (2010). Usefulness of percutaneous aortic valve implantation to 
improve quality of life in patients > 80 years of age. Am J Cardiol, 106, 1777–1781, 
ISSN 0002-9149 
Ben-Dor, I., Pichard, A., Gonzalez, M.A., Weissman, G., Li, Y., Goldstein, S.A., Okubagzi, P., 
Syed, A.I., Maluenda, G., Collins, S.D., Delhaye, C., Wakabayashi, K., Gaglia, M.A., 
Torguson, R., Xue, Z., Satler, L.F., Suddath, W.O., Kent, K.M., Lindsay J., & 
Waskman R. (2010). Correlates and causes of death in patients with severe 
symptomatic aortic stenosis who are not eligible to participate in a clinical trial of 
transcatheter aortic valve implantation. Circulation, 122 (Suppl 1), S37–S42, ISSN 
0009-7322 
Bergman, H., Ferrucci, L., Guralnik, J., Hogan, D.B., Hummel, S., Karunananthan, S., & 
Wolfson, C. (2007). Frailty: an emerging research and clinical paradigm – issues and 
controversies. J Gerontol A Biol Sci Med Sci, 62, 731–737, ISSN 1079-506 
www.intechopen.com
 
Relationship Between Aortic Valve Replacement and Old Age 
 
181 
Bleiziffer, S., Ruge, H., Mazzitelli, D., Schreiber, C., Hutter, A., Laborde, J.C., Bauernschmitt, 
R., & Lange, R. (2009). Results of percutaneous and transapical transcatheter aortic 
valve implantation performed by a surgical team. Eur J Cardiothorac Surg, 35, 615–
621, ISSN 1010-7940 
Bonow, R.O., Carabello, B.A., Chatterjee, K., de Leon, A.C., Faxon, D.P., Freed, M.D., 
Gaasch, W.H., Lytle, B.W., Nishimura, R.A., O’Gara, P.T., O’Rourke, R.A., Otto, C., 
Shah, P.M., Shanewise, J.S., Smith, S.C., Jacobs, A.K., Adams, C.D., Anderson, J.L., 
Antman, E.M., Faxon, D.P., Fuster, V., Halperin, J.L., Hiratzka, L.F., Hunt, S.A., 
Lytle, B.W., Nishimura, R., Page, R.L., & Riegel, B. (2006). ACC/AHA 2006 practice 
guidelines for the management of patients with valvular heart disease: a report of 
the American College of Cardiology/American Heart Task Force on Practice 
Guidelines (Writing Committee to revise the 1998 guidelines for the management 
of patients with valvular heart disease). J Am Coll Cardiol, 48, e1–e148, ISSN 0735-
1097 
Bouchon, J.P. (1984). 1 + 2 + 3. Comment être efficace en Gériatrie. Rev Prat, 34, 888–892,  
ISSN 0035–2640 
Bouma, B.J., van der Brink, R.B.A., van der Meulen, J.H.P., Chereix, E.C., Hamer, H.P.M., 
Dekker, E., Lie, K.I., & Tijssen, J.G.P. (1999). To operate or not on elderly patients 
with aortic stenosis: the decision and its consequences. Heart, 82, 143–148, ISSN 
1355-6037 
Chan, E.D., & Welsh, C.H. (1998). Geriatrics respiratory medicine. Chest, 114, 1704–1733, 
ISSN 0012-8703 
Chiappini, B., Camurri, N., Loforte, A., Di Marco, L., Di Bartolomeo, R., & Marinelli, G. 
(2004). Outcome after aortic valve replacement in octogenarians. Ann Thorac Surg, 
78, 85–89, ISSN 0003-4975 
Chizner, M.A., Pearle, D.L., & deLeon, A.C. (1980). The natural history of aortic stenosis in 
adults. Am Heart J, 99, 419–424, ISSN 0002-8703 
Collart, F., Feier, H., Kerbaul, F., Mouly-Bandini, A., Riberi, A., Mesana, T.G., & Metras, D. 
(2005). Valvular surgery in octogenarians: operative risks factors, evaluation of 
EuroSCORE and long term results. Eur J Cardiothorac Surg, 27, 276–280, ISSN 1010-
7940 
Cribier, A., Eltchaninoff, H., Bash, A., Borenstein, N., Tron, C., Bauer, F., Derumeaux, G., 
Anselme, F., Laborde, F., & Leon, M.B. (2002). Percutaneous transcatheter 
implantation of an aortic valve prosthesis for calcific aortic stenosis: first human, 
case description. Circulation, 106, 3006–3008, ISSN 0009-7322 
Culliford, A.T., Galloway, A.C., Colvin, S.B., Grossi, E.A., Baumann, G., Esposito, R., 
Ribakove, G.H., & Spencer, F.C. (1991). Aortic valve replacement for aortic stenosis 
in persons aged 80 years and over. Am J Cardiol, 67, 1256–1260, ISSN 0002-9149  
Dasgupta, M., Rolfson, D.B., Stolee, P., Borrie, M.J., & Speechley, M. (2009). Frailty is 
associated with postoperative complications in older patients with medical 
problems. Arch Gerontol Geriatr, 48, 78–83, ISSN 0167-4943 
Dewey, T.M., Brown, D., Ryan, W.H., Herbert, M.A., Prince, S.L., & Mack, M.J. (2007). 
Reliability of risk algorithms in predicting early and late operative outcomes. J 
Thorac Cardiovasc Surg, 135, 180–187, ISSN 0022-5223 
Eder, B., Hofmann, P., von Duvillard, S.P., Brandt, D., Schmid, J.P., Pokan, R., & Wonisch, 
M. (2010). Early 4-week cardiac rehabilitation exercise training in elderly patients 
after heart surgery. J Cardiopulm Rehabil Prev, 30, 85–92, ISSN 1932-7501 
www.intechopen.com
 
Aortic Valve Surgery 
 
182 
Edmunds, L.H., Jr., Stephenson, L.W., Edie, R.N., & Ratcliffe, M.B. (1988). Open-heart 
surgery in octogenarians. N Engl J Med, 319, 131–136, ISSN 0028-8614  
Edwards, M.B, Taylor, M.P., & Taylor, K.M. (2003). Outcomes in nonagenarians after heart 
valve replacement operation. Ann Thorac Surg, 75, 830–834, ISSN 0003-4975 
Elayda, M.A., Reul, R.M., Alonzo, D.M., Gillette, N., Reul, G.J., Jr., & Cooley, D.A. (1993) 
Aortic valve replacement in patients 80 years and older. Operative risks and long 
term results. Circulation, 88, II11–II16, ISSN 0009-7322 
Eltchaninoff, H., Cribier, A., Tron, C., Anselme, F., Koning, R., Soyer, R., & Letac, B. (1995). 
Balloon aortic valve valvuloplasty in elderly patients at high risk for surgery, or 
inoperable: an alternative to valve replacement? Eur Heart J, 16, 1079–1084, ISSN 
0195-668X 
Ferrucci, L., Guralnik, J.M., Studenski, S., Fried, L.P., Cutler, G.B., Jr., & Watson, J.D. (2004). 
Designing randomized controlled trials aimed at preventing or delaying functional 
decline and disability in frail, older persons: a consensus report. J Am Geriatr Soc, 
52, 625–634, ISSN 0002-8614 
Florath, I., Albert, A., Boening, A., Ennker, I.C., & Ennker, J. (2010). Aortic valve replacement 
in octogenarians: identification of high-risk patients. Eur J Cardiothorac Surg, 37, 
1304–1310, ISSN 1010-7940 
Folkmann, S., Gorlitzer, M., Weiss, G., Harrer, M., Thalmann, M., Poslussny, P., & 
Grabenwoger, M. (2010). Quality of life in ocotogenarians one year after aortic 
valve replacement with or without coronary artery bypass surgery. Interact 
Cardiovasc Thorac Surg, 11, 750–753, ISSN 1569-9293 
Freed, B.H., Sugeng, L., Furlong, K., Mor-Avi, V., Raman, J., Jeevanandam, V., & Lang, R.M. 
(2010). Reasons for nonadherence to guidelines for aortic valve replacement in 
patients with severe aortic stenosis and potential solutions. Am J Cardiol, 105, 1339–
1342, ISSN 0002-9149 
Freeman, W.K., Schaff, H.V., Orszulak, T.A., & Tajik, A.J. (1991). Cardiac surgery in the 
octogenarian: outcome and clinical follow-up. J Am Coll Cardiol, 18, 29–35, ISSN 
0735-1097 
Fried, L.P., Ferrucci, L., Darer, J., Williamson, J.D., & Anderson, G. (2004). Untangling the 
concepts of disability, frailty, and comorbidity: implications for improved targeting 
and care. J Gerontol A Biol Sci Med Sci, 59, 255–263, ISSN 1079-5006  
Ghanem, A., Muller, A., Nähle, C.P., Kocurek, J., Werner, N., Hammerstingl, C., Schild, 
H.H., Schwab, J.O., Mellert, F., Fimmers, R., Nickenig, G., & Thomas, D. (2010). 
Risk and fate of cerebral embolism after transfemoral aortic valve implantation.  
J Am Coll Cardiol, 55, 427–432, ISSN 0735-1097 
Gill, T.M., Allore, H.G., Holford, T.R., & Guo, Z. (2004). Hospitalization, restricted activity 
and the development of disability among older persons. JAMA, 292, 2115–2124, 
ISSN 0098-7484 
Grube, E., Schuler, G., Buellesfeld, L., Gerckens, U., Linke, A., Wenaweser, P., Sauren, B., 
Mohr, F.W., Walther, T., Zickmann, B., Iversen, S., Felderhoff, T., Cartier, R., & 
Bonan, R. (2007). Percutaneous aortic valve replacement for severe aortic stenosis in 
high-risk patients using the second- and the current third-generation self-
expanding CoreValve prosthesis. J Am Coll Cardiol, 50, 69–76, ISSN 0735-1097 
Health at a glance OECD indicators. www.sourceoecd.org/socialissues/9789264061538 
Horstkotte, D., & Loogen, F. (1988). The natural history of aortic valve replacement. Eur 
Heart J, 9 (Suppl E), 57–64, ISSN 0195-668X 
www.intechopen.com
 
Relationship Between Aortic Valve Replacement and Old Age 
 
183 
Huber, C.H., Goeber, V., Berdat, P., Carrel, T., & Eckstein, F. (2007). Benefits of cardiac 
surgery in octogenarians – a postoperative quality of life assessment. Eur J 
Cardiothorac Surg, 31, 1099–1105, ISSN 1010-7940 
Iung, B., Cachier, A., Baron, G., Messika-Zeitoun, D., Delahaye, F., Tornos, P., Gohlke-
Bärwolf, C., Boersma, E., Ravaud, P., & Vahanian, A. (2005). Decision-making in 
elderly patients with severe aortic stenosis: why are so many denied surgery? Eur 
Heart J, 26, 2714–2720, ISSN 0195-668X  
Jilaihawi, H., Chin, D., Vasa-Nicotera, M., Jeilan, M., Spyt, T., Ng, G.A., Bence, J., Logtens, 
E., & Kovac, J. (2009). Predictors for permanent pacemaker requiring after 
transcatheter aortic valve implantation with the CoreValve bioprosthesis. Am Heart 
J, 157, 860–866, ISSN 0002-8703 
Johansson, M., Nozohoor, S., Kimblad, P.O., Harnek, J., Olivecrona, G.K., & Sjögren, J. 
(2011). Transapical versus transfemoral aortic valve implantation: a comparison of 
survival and safety. Ann Thorac Surg, 91, 57–63, ISSN 0003-4975 
Jones, D., Song, X., Mitnitski, A., & Rockwood, K. (2005). Evaluation of a frailty index based 
on a comprehensive geriatric assessment in a population based study of elderly 
Canadians. Aging Clin Exp Res, 17, 465–471, ISSN 1594-0667 
Karunananthan, S., Wolfson, C., Bergman, H., Beland, F., & Hogan, D.B. (2009).  
A multidisciplinary systematic literature review on frailty: overview of the 
methodology used by the Canadian Initiative on Frailty and Aging. BMC Med Res 
Methodol, 12, 68, ISSN 1471-2288 
Knaus, W.A., Wagner, D.P., Zimmerman, J.E., & Draper, E.A. (1993). Variations in mortality 
and length of stay in intensive care units. Ann Intern Med, 118, 753–761, ISSN 0003-
4819 
Kolh, P., Kerzmann, A., Honore, C., Comte, L., & Limet, R. (2007). Aortic valve surgery in 
octogenarians: predictive factors of operative and long-term results. Eur J 
Cardiothorac Surg, 31, 600–606, ISSN 1010-7940 
Krane, M., Deutsch, M.A., Bleizziffer, S., Schneider, L., Ruge, H., Mazzitelli, D., Schreiber, C., 
Brockmann, G., Voss, B., Bauernschmitt, R. & Lange, R. (2010). Quality of life 
among patients undergoing transcatheter aortic valve implantation. Am Heart J, 
160, 451–457, ISSN 0002-8703 
Langanay, T., De Latour, B., Ligier, K., Derieux, T., Agnino, A., Verhoye, J.P., Corbineau, J., 
& Leguerrier, A. (2004). Surgery for aortic stenosis in octogenarians: influence of 
coronary disease and other comorbidities on hospital mortality. J Heart Valve Dis, 
13, 545–552, ISSN 0966-8519 
Langanay, T., Verhoye, J.P., Ocampo, G., Vola, M., Tauran, A., De La Tour, B., Derieux, T., 
Ingels, A., Corbineau, H., & Leguerrier, A. (2006). Current hospital mortality of aortic 
valve replacement in octogenarians. J Heart Valve Dis, 15, 630–637, ISSN 0966-8519 
Lee, D.H., Buth, K.J., Martin, B.J., Yip, A.M., & Hirsch, G.M. (2010). Frail patients are at 
increased risk for mortality and prolonged institutional care after cardiac surgery. 
Circulation, 121, 973–978, ISSN 0009-7322  
Lefèvre, T., Kappetein, A.P., Wolner, E., Nataf, P., Thomas, M., Schächinger, V., De Bruyne, 
B., Eltchaninoff, H., Thielmann, M., Himbert, D., Romano, M., Serruys, P., & 
Wilmmer-Greinecker, G., on behalf PARTNER EU Investigator Group. (2011). One 
year follow-up of the multi-centre European PARTNER transcatheter heart valve 
study. Eur Heart J, 32, 148–157, 0195-668X 
Leon, M.B., Smith, C.R., Miller, M.M., Moses J.W., Svensson, L.G., Tuzcu, E.M., Webb, J.G., 
Fontana, G.P., Makkar, R.R., Brown, D.L., Block, P.C., Guyton, R.A., Pichard, A.D., 
www.intechopen.com
 
Aortic Valve Surgery 
 
184 
Bavaria, J.E., Herrmann, H.C., Douglas, P.S., Peterson, J.L., Akins, J.J., Anderson, 
W.N., Wang, D., & Pocock, S., for the PARTNER Trial investigators. (2010). 
Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot 
undergo surgery. N Engl J Med, 363, 1597–1607, ISSN 0028-8614 
Leonteyv, S., Walther, T., Borger, M.A., Lehmann, S., Funkat, A.K., Kempfert, J., Falk, V., & 
Morh, F.W. (2009). Aortic valve replacement in octogenarians: utility of risk 
stratification with EuroSCORE. Ann Thorac Surg, 87, 1440–1445, ISSN 0003-4975 
Levinson, J.R., Akins, C.W., Buckley, M.J., Newell, J.B., Palacios, I.F., Blosk, P.C., & Fifer, 
M.A. (1989). Octogenarians with aortic stenosis. Outcome after aortic valve 
replacement. Circulation, 80, 49–56, ISSN 0009-7322 
Macchi, C., Fattirolli, F., Lova, R.M., Conti, A.A., Luisi, M.L., Intini, R., Zipoli, R., Burgisser, 
C., Guarducci, L., Masotti, G., & Gensini, G.F. (2007). Early and late rehabilitation 
and physical training in elderly patients after cardiac surgery. Am J Phys Med 
Rehabil, 86, 826–834, ISSN 0894-9115 
Macchi, C., Polcaro, P., Cecchi, F., Zipoli, R., Sofi, F., Romanelli, A., Pepi, L., Sibilo, M., 
Lipoma, M., Petrelli, M., & Molino-Lova, R. (2009). One-year adherance to exercise 
in elderly patients receiving postacute inpatient rehabilitation after cardiac surgery. 
Am J Phys Med Rehabil, 88, 727–734, ISSN 0894-9115  
Makary, M.A., Segev, D.L., Pronovost, P.J., Syin, D., Bandeed-Roche, K., Patel, P., Takenaga, 
R., Dervgan, L., Holzmueller, C.G., Tian, J., & Fried, L.P. (2010). Frailty as a 
predictor of surgical outcomes in older patients. J Am Coll Surg, 210, 901–908, ISSN 
S1072-7515 
Maillet, J.M., Somme, D., Hennel, E., Lessana, A., Saint-Jean, O., & Brodaty, D. (2009). Frailty 
after aortic valve replacement in octogenarians. Arch Gerontol Geriatr, 48, 391–396, 
ISSN 0167-4943  
Mazza, A., Camera, F., Maestri, A., Longoni, F., Patrignani, A., Gualco, A., Opasich, C., & 
Cobeli, F. (2007). Elderly patient-centered rehabilitation after cardiac surgery. 
Monaldi Arch Chest Dis, 68, 36–43, ISSN 1112–0643 
Melby, S.J., Zierer, A., Kaiser, S.P., Guthrie, T.J., Keune, J.D., Schuessler, R.B., Pasque, M.K., 
Lawton, J.S., Moazami, N., Moon, M.R., & Damiano, R.J., Jr. (2007). Aortic valve 
replacement in octogenarians: risk factors for early and late mortality. Ann Thorac 
Surg, 83, 1651–1657, ISSN 0003-4975 
Messika-Zeitoun, D., Serfaty, J.M., Brochet, E., Ducrocq, D., Lepage, L., Detaint, D., Hyafil, 
F., Himbert, D., Pasi, N., Laissy, J.P., Iung, B., & Vahanian, A. (2010). Multimodal 
assessment of the aortic annulus diameter: implications for transcatheter aortic 
valve implantation. J Am Coll Cardiol, 55, 186–194, ISSN 0735-1097 
Needham, D.M. (2008). Mobilizing patients in the intensive care unit: neuromuscular 
weakness and physical function. JAMA, 300, 1685–1690, ISSN 0098-7484 
NHLBI Balloon Valvuloplasty Registry participants. (1991). Percutaneous balloon aortic 
valvuloplasty: acute and 30-day follow-up results from the NHLBI Balloon 
Valvuloplasty Registry. Circulation, 84, 2383–2397. ISSN 0009-7322 
Nkomo, V., Gardin, J.M., Skelton, T.N., Gottdiener, J.S., Scott, C.G., & Enriquez-Sarano, E. 
(2006). Burden of valvular heart diseases: a population-based study. Lancet. 368, 
1005–1011, ISSN 0140-6736 
Olsson, M., Granstrom, L., Lindblom, D., Rosenqvist, M., & Ryden, L. (1992). Aortic valve 
replacement in octogenarians with aortic stenosis: a case study. J Am Coll Cardiol, 
20, 1512–1516, ISSN  0735-1097  
www.intechopen.com
 
Relationship Between Aortic Valve Replacement and Old Age 
 
185 
Olsson, M., Janfjall, H., Orth-Gomer, K., Unden, A., & Rosenqvist, M. (1996). Quality of life 
in octogenarians after valve replacement due to aortic stenosis. Eur Heart J, 17, 583–
589, 0195-668X 
Opasich, C., Patrignani, A., Mazza, A., Gualco, A., Cobelli, F., & Pinna, G.D. (2010). An 
elderly-centered, personalized, physiotherapy program early after cardiac surgery. 
Eur J Cardiovasc Prev Rehabil, 17, 582–587, ISSN S1741-8267 
Parolari, A., Pesce, L.L., Trezzi, M., Cavallotti, L., Kassem, S., Loardi, C., Pacini, D., Tremoli, 
E., & Alamanni, F. (2010). EuroSCORE performance in valve surgery: a meta-
analysis. Ann Thorac Surg, 89, 787–793, ISSN 0003-4975 
Pasquali, S.K., Alexander, K.P., & Peterson, E.D. (2001). Cardiac rehabilitation in the elderly. 
Am Heart J, 142, 748–755, ISSN 0002-8703 
Praschker, B.G.L., Leprince, P., Bonnet, N., Rama, A., Bors, V., Liévre, L., Pavie, A., & 
Gandjbakch, I. (2006). Cardiac surgery in nonagenarians: hospital mortality and 
long-term follow-up. Interact Cardiovasc Thorac Surg, 5, 696–700, ISSN 1569-9293 
Province, M.A., Hadley, E.C., Hornbrook, M.C., Lipsitz, L.A., Miller, J.P., Mulrow, C.D., 
Ory, M.G., Sattin, R.W., Tinetti, M.E., & Wolf, S.L. (1995). The effects of exercise on 
falls in elderly patients. A preplanned meta-analysis of the FICSIT trials. Frailty and 
Injuries: Cooperative Studies of Intervention Techniques. JAMA, 273, 1341–1347, 
ISSN 0098-7484 
Robinson, T.N., Eiseman, B., Wallace, J.L., Church S.D., McFann, K.K., Pfister, S.M., Sharp, 
T.J., & Moss, M. (2009). Redefining geriatric preoperative assessment using frailty, 
disability and co-morbidity. Ann Surg, 250, 449–455, ISSN 0003-4932  
Rockwood, K. (2005). Frailty and its definition: a worthy challenge. J Am Geriatr Soc, 53, 
1069–1070, ISSN 0002-8614 
Roques, F., Michel, P., Goldstone, A.R., Nashef, S. (2003). The Logistic EuroSCORE. Eur 
Heart J, 24, 881–882, ISSN 0195-668X 
Ross, J., & Braunwald, E. (1968). Aortic stenosis. Circulation, 38(Suppl I), I61–I67, ISSN 0009-
7322 
Roten, L., Wenaweser, P., Delacretaz, E., Hellige, G., Stortecky, S., Tanner, H., Pilgrim, T., 
Kadner, A., Eberle, B., Zwahlen, M., Carrel, T., Meier, B., & Windecker, S. (2010). 
Incidence and predictors of atrioventricular conduction impairment after 
transaortic valve implantation. Am J Cardiol, 106, 1473–1480, ISSN 0002-9149 
Rydwik, E., Lammes, E., Frändin, K., & Akner, G. (2008). Effects of a physical and 
nutritional intervention program for a frail elderly people over age 75. A 
randomized controlled pilot treatment trial. Aging Clin Exp Res, 20, 159–170, ISSN 
1594-0667 
Scharwz, F., Baumann, P., Manthey, J., Hoffmann, M., Schuler, G., Mehmel, H.C., Schmitz, 
W., & Kübler, W. (1982). The effect of aortic valve replacement on survival. 
Circulation, 66, 1105–1110, ISSN 0009-7322 
Shroyer, A.L., Coombs, L.P., Peterson, E., Eiken, M.C., DeLong, E.R., Chen, A., Ferguson, 
T.B., Grover, F.L., & Edwards, F; Society of Thoracic Surgeons. (2003). The Society 
of Thoracic Surgeons: 30-day operative mortality and morbidity risk models. Ann 
Thorac Surg, 75, 1856–1865, ISSN 0003-4975 
Schueler, R., Hammersting, C., Sinning, J.M., Nickenig, G., & Omran, H. (2010). Prognosis of 
octogenarians with severe aortic valve stenosis at high risk for cardiovascular 
surgery. Heart, 96, 1831–1836, ISSN 1355-6037 
www.intechopen.com
 
Aortic Valve Surgery 
 
186 
Sjögren, J., & Thulin, L.I. (2004). Quality of life in the very old elderly after cardiac surgery: a 
comparison of SF-36 between long term survivors and an age-matched population. 
Gerontology, 50, 407–410, ISSN 0304-324X 
Somme, D., Maillet, J.M., & Fagon, J.Y. (2009). Particularités physiologiques du sujet âgé, In: 
Réanimation Médicale sous l’égide du Collége National des Enseignants de 
Réanimation Médicale, pp. 218–225, Masson, Paris, ISBN 978-2-294-08855-1  
Stoica, S.C., Cafferty, F., Kitcat, J., Baskett, R.J.F., Goddard, M., Sharples, L.D., Wells, F.C., & 
Nashef, S.A.M. (2006). Octogenarians undergoing cardiac surgery outlive their 
peers: a case for early referral. Heart, 92, 503–506, ISSN 1355-6037 
Sundt, T.M., Bailey, M.S., Moon, M.R., Mendeloff, E.N., Huddleston, C.B., Pasque, M.K., 
Barner, H., & Gay, Jr, W.C. (2000). Quality of life after aortic valve replacement at 
the age of > 80 years. Circulation, 102 (Suppl III), III70–III74, ISSN 0009-7322 
Tamburino, C., Capodanno, D., Ramondo, A., Petronio, A.S., Ettori, F., Santoro, G., 
Klugmann, S., Bedogni, F., Maisano, F., Marzocchi, A., Poli, A., Antoniucci, D., 
Napodano, M., De Carlo, M., Fiorina, C., & Ussia, G.P. (2011). Incidence and 
predictors of early and late mortality after transcatheter aortic valve implantation 
in 663 patients with severe aortic stenosis. Circulation, 123, 299–308, ISSN 0009-7322 
Thourani, V.H., Myung, R., Kilgo, P., Thompson, K., Puskas J.D., Lattouf, O.M., Cooper, 
W.A., Vega, J.D., Chen, E.P., & Guyton, R.A. (2008). Long-term outcome after 
isolated aortic valve replacement in octogenarians: a modern perspective. Ann 
Thorac Surg, 86, 1458–1465, ISSN 0003-4975 
Tsai, T.P., Chaux, A., Matloff, J.M., Gray, R.J., DeRobertis, M.A., & Khan, S.S. (1994). Ten-
year experience of cardiac surgery in patients aged 80 years and over. Ann Thorac 
Surg, 58, 445–450, ISSN 0003-4975 
Vahanian,A. & Otto, C.M.( 2010). Risk stratification of patients with aortic stenosis. Eur 
Heart J, 31, 416–423, ISSN 0195-668X 
Vahanian, A., Baumgartner, H., Bax, J., Butchard, E., Dion, R., Filippatos, G., Flachskampf, 
F., Hall, R., Iung, B., Kasprzak, J., Nataf, P., Tornos, P., Torracca, L., & Wenink, A. 
(2007). Guidelines on the management of valvular heart disease. The Task Force on 
the Management of Valvular Heart Disease of the European Society of Cardiology. 
Eur Heart J, 28, 230–268, ISSN 0195-668X 
Varadarajan, P., Kapoor, N., Bansal, R.C., & Pai, R.G. (2006). Clinical profile and natural 
history of 453 non surgically managed patients with severe aortic stenosis. Ann 
Thorac Surg, 82, 2111–2115, ISSN 0003-4975 
Vicchio, M., Della Corte, A., De Santo, L.S., De Feo, M., Caianiello, G., Scardone, M., & 
Cotrufo, M. (2008). Tissue versus mechanical prostheses: quality of life in 
octogenarians. Ann Thorac Surg, 85, 1290–1295, ISSN 0003-4975  
Wang, P., Acker, M.A., Bilello, M., Melhem, E.R., Stambrook, E., Ratcliffe, S.J., & Floyd, T.F.; 
DENOVO (determining neurologic outcomes from valve operations) investigators. 
(2010). Sex, ageing and preexisting cerebral ischemic disease in patients with aortic 
stenosis. Ann Thorac Surg, 90, 1230–1235, ISSN 0003-4975 
Webb, J.G., Altwegg, L., Boone, R.H., Cheung, A., Ye, J., Lichtenstien, S., Lee, M., Masson, 
J.B., Thompson, C., Moss, R., Carere, R., Munt, B., Nietlispach, F., & Humphries, K. 
(2009). Transcatheter aortic valve implantation. Impact on clinical and valve-related 
outcomes. Circulation, 119, 3009–3016, ISSN 0009-7322 
Zajarias, A. & Cribier, A.G. (2009). Outcomes and safety of percutaneous aortic valve 
replacement. J Am Coll Cardiol, 53, 1829–1836, ISSN 0735-1097 
www.intechopen.com
Aortic Valve Surgery
Edited by Prof. Noboru Motomura
ISBN 978-953-307-600-3
Hard cover, 246 pages
Publisher InTech
Published online 22, December, 2011
Published in print edition December, 2011
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
The aortic valve is located at the center of the heart. It is the core of cardiac anatomy and aortic valve surgery
has led the field of cardiac surgery. This book describes all aspects of aortic valve surgery and it will help
clarify daily questions regarding the clinical practice in aortic valve surgery, as well as induce inspiration and
new insights into this field.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Jean-Michel Maillet and Dominique Somme (2011). Relationship Between Aortic Valve Replacement and Old
Age, Aortic Valve Surgery, Prof. Noboru Motomura (Ed.), ISBN: 978-953-307-600-3, InTech, Available from:
http://www.intechopen.com/books/aortic-valve-surgery/relationship-between-aortic-valve-replacement-and-old-
age
© 2011 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
